The economic burden of chronic obstructive pulmonary disease (COPD) in the USA, Europe, and Asia: results from a systematic review of the literature-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The economic burden of chronic obstructive pulmonary disease (COPD) in the USA, Europe, and Asia: results from a systematic review of the literature

Published:2019-10-18 Issue:6 Volume:20 Page:661-672
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Anees ur Rehman ¹²^ORCID,Ahmad Hassali Mohamed Azmi¹,Muhammad Sohail Ayaz³,Shah Shahid⁴,Abbas Sameen⁵,Hyder Ali Irfhan Ali Bin⁶,Salman Ahmad⁷

Affiliation:

1. Department of Clinical Pharmacy, School of Pharmaceutical Sciences, University Sains Malaysia, Penang, Malaysia

2. Faculty of Pharmacy, Bahauddin Zakariya University Multan, Multan, Pakistan

3. School of Management Sciences, University Sains Malaysia, Penang, Malaysia

4. Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Government College University, Faisalabad, Pakistan

5. Department of Pharmacy, Quaid e Azam University Islamabad, Islamabad, Pakistan

6. Respiratory Department, Hospital Pulau Pinang, Penang, Ministry of Health Malaysia, Penang, Malaysia

7. School of Management, COMSATS University Islamabad, Islamabad, Pakistan

Funder

not funded

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2020.1678385

Reference62 articles.

1. Geographical distribution of COPD prevalence in Europe, estimated by an inverse distance weighting interpolation technique

2. International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study

3. Global burden of COPD: risk factors, prevalence, and future trends

4. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

5. Projections of Global Mortality and Burden of Disease from 2002 to 2030

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the effectiveness of inhalation therapy in patients with chronic airway diseases: A new digital measurement;Respiratory Medicine and Research;2024-11

2. The direct cost of chronic kidney disease (CKD) reported in Asian countries; a systematic literature review;Cost Effectiveness and Resource Allocation;2024-09-05

3. Economic burden of chronic obstructive pulmonary disease and post-tuberculosis sequelae in low- and middle-income countries: a database compiled from a systematic review and meta-analysis;BMJ Public Health;2024-07

4. Discovery, Multiparametric Optimization, and Solid-State Driven Identification of CHF-6550, a Novel Soft Dual Pharmacology Muscarinic Antagonist and β₂ Agonist (MABA) for the Inhaled Treatment of Respiratory Diseases;Journal of Medicinal Chemistry;2024-06-10

5. Impact of bevacizumab on clinical outcomes and its comparison with standard chemotherapy in metastatic colorectal cancer patients: a systematic review and meta-analysis;Journal of Pharmaceutical Policy and Practice;2024-06-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3